3 chapters across the catalog
Remdesivir and Melatonin, COVID-19 Therapeutic Research
Research into COVID-19 therapeutics suggests that the active metabolite in Remdesivir, GS-441524, is also known as a feline antiviral. Additionally, studies indicate that melatonin may inhibit the cytokine storm induced by COVID-19. The hosts discuss the common household use of melatonin for sleep and jet lag.
A listener provides insight into "Non-24," a circadian rhythm disorder common among blind individuals whose brains do not receive light cues to regulate sleep cycles. The discussion questions whether new medications for the condition are legitimate medical breakthroughs or "scams" designed to repurpose expiring patents.
Melatonin Potential for Ebola Treatment, Pineal Research Journal
An abstract from the Journal of Pineal Research suggests that melatonin could be a viable treatment for Ebola virus infections. The study highlights melatonin's ability to target endothelial disruption and its successful use in treating septic shock. Proponents argue that melatonin's high safety profile and oral administration make it suitable for large-scale outbreaks.
